Omnimoxa Pf (Moxifloxacin Hydrochloride)

Moxifloxacin, the active ingredient in Omnimoxa Pf, is a fluoroquinolone antibiotic presented as an ophthalmic solution for topical eye use. It treats bacterial eye infections such as conjunctivitis and keratitis in adult and pediatric patients. GNH USA supplies Omnimoxa Pf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Omnimoxa Pf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omnimoxa Pf is a fluoroquinolone ophthalmic antibacterial that targets bacterial pathogens of the ocular surface.

- Bacterial conjunctivitis: reduces bacterial load and speeds the resolution of redness and discharge. - Bacterial keratitis: penetrates corneal tissue to eradicate the infecting organisms and promote healing. - Post‑surgical prophylaxis: applied after eye surgery to prevent bacterial contamination and infection. - Acute bacterial blepharitis: diminishes bacterial colonisation on the eyelid margin. - External ocular inflammation: helps control infection‑related inflammation. - Contact lens‑associated keratitis: treats infection linked to contaminated lenses.

Moxifloxacin ophthalmic solution may elicit local and systemic reactions.

Common Side Effects: - Stinging or burning sensation upon instillation. - Temporary blurred vision. - Mild eye irritation. - Redness of the conjunctiva. - Tearing or watery eyes. - Foreign‑body sensation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angio‑edema). - Corneal ulceration or melting. - Persistent or worsening eye pain. - Vision loss. - Endophthalmitis. - Stevens‑Johnson syndrome.

Omnimoxa Pf should be used only when prescribed.

- Contraindication: Do not use if there is a known hypersensitivity to moxifloxacin or other fluoroquinolones. - Caution: Monitor     - Caution   - Cullet  -   -   - Store  

The   

    t